nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—CYP3A4—Guanethidine—hypertension	0.0635	0.11	CbGbCtD
Temozolomide—CYP3A4—Hydralazine—hypertension	0.0481	0.0837	CbGbCtD
Temozolomide—CYP3A4—Guanfacine—hypertension	0.0409	0.0712	CbGbCtD
Temozolomide—CYP3A4—Isradipine—hypertension	0.0365	0.0634	CbGbCtD
Temozolomide—CYP3A4—Nisoldipine—hypertension	0.0321	0.0559	CbGbCtD
Temozolomide—CYP3A4—Indapamide—hypertension	0.0321	0.0559	CbGbCtD
Temozolomide—CYP3A4—Diltiazem—hypertension	0.031	0.0539	CbGbCtD
Temozolomide—CYP3A4—Eplerenone—hypertension	0.031	0.0539	CbGbCtD
Temozolomide—CYP3A4—Enalapril—hypertension	0.0276	0.0481	CbGbCtD
Temozolomide—CYP3A4—Irbesartan—hypertension	0.0253	0.044	CbGbCtD
Temozolomide—CYP3A4—Amlodipine—hypertension	0.0248	0.0431	CbGbCtD
Temozolomide—CYP3A4—Felodipine—hypertension	0.0239	0.0416	CbGbCtD
Temozolomide—CYP3A4—Nifedipine—hypertension	0.0231	0.0402	CbGbCtD
Temozolomide—CYP3A4—Nicardipine—hypertension	0.0228	0.0396	CbGbCtD
Temozolomide—CYP3A4—Carvedilol—hypertension	0.0228	0.0396	CbGbCtD
Temozolomide—CYP3A4—Propranolol—hypertension	0.0209	0.0364	CbGbCtD
Temozolomide—CYP3A4—Clonidine—hypertension	0.02	0.0348	CbGbCtD
Temozolomide—CYP3A4—Atorvastatin—hypertension	0.0178	0.031	CbGbCtD
Temozolomide—CYP3A4—Losartan—hypertension	0.0163	0.0283	CbGbCtD
Temozolomide—CYP3A4—Verapamil—hypertension	0.0144	0.025	CbGbCtD
Temozolomide—CYP3A4—Aflatoxin B1 metabolism—EPHX1—hypertension	0.000659	0.0552	CbGpPWpGaD
Temozolomide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—hypertension	0.000539	0.0452	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—AOC1—hypertension	0.000395	0.0331	CbGpPWpGaD
Temozolomide—CYP3A4—Irinotecan Pathway—CYP3A5—hypertension	0.000297	0.0249	CbGpPWpGaD
Temozolomide—CYP3A4—Irinotecan Pathway—ABCC1—hypertension	0.000287	0.024	CbGpPWpGaD
Temozolomide—CYP3A4—Fatty Acid Omega Oxidation—CYP4A11—hypertension	0.000277	0.0232	CbGpPWpGaD
Temozolomide—CYP3A4—Xenobiotics—CYP2J2—hypertension	0.000276	0.0231	CbGpPWpGaD
Temozolomide—CYP3A4—Estrogen metabolism—STS—hypertension	0.000263	0.0221	CbGpPWpGaD
Temozolomide—CYP3A4—Aflatoxin activation and detoxification—CYP3A5—hypertension	0.000233	0.0195	CbGpPWpGaD
Temozolomide—CYP3A4—Xenobiotics—CYP3A5—hypertension	0.000223	0.0187	CbGpPWpGaD
Temozolomide—CYP3A4—Tamoxifen metabolism—CYP3A5—hypertension	0.000215	0.018	CbGpPWpGaD
Temozolomide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—hypertension	0.00021	0.0176	CbGpPWpGaD
Temozolomide—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—hypertension	0.000179	0.015	CbGpPWpGaD
Temozolomide—CYP3A4—Xenobiotics—CYP2C18—hypertension	0.000176	0.0147	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—CYP4F12—hypertension	0.000164	0.0137	CbGpPWpGaD
Temozolomide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—hypertension	0.000163	0.0136	CbGpPWpGaD
Temozolomide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP4A11—hypertension	0.000159	0.0133	CbGpPWpGaD
Temozolomide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP3A5—hypertension	0.000153	0.0128	CbGpPWpGaD
Temozolomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4A11—hypertension	0.000152	0.0127	CbGpPWpGaD
Temozolomide—CYP3A4—Constitutive Androstane Receptor Pathway—ALAS1—hypertension	0.000143	0.012	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—CYP2J2—hypertension	0.000142	0.0119	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4F12—hypertension	0.000133	0.0111	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP4F12—hypertension	0.000131	0.011	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B1—hypertension	0.000122	0.0103	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP11B1—hypertension	0.000121	0.0101	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2J2—hypertension	0.000114	0.00959	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP2J2—hypertension	0.000113	0.00946	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—TPH1—hypertension	0.000111	0.00928	CbGpPWpGaD
Temozolomide—CYP3A4—Estrogen metabolism—COMT—hypertension	0.000108	0.00903	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP4F12—hypertension	0.000107	0.00901	CbGpPWpGaD
Temozolomide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—hypertension	0.000106	0.00888	CbGpPWpGaD
Temozolomide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—hypertension	0.000103	0.0086	CbGpPWpGaD
Temozolomide—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—hypertension	0.000102	0.00852	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B1—hypertension	9.92e-05	0.00831	CbGpPWpGaD
Temozolomide—CYP3A4—Estrogen metabolism—GSTM1—hypertension	9.86e-05	0.00826	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4A11—hypertension	9.63e-05	0.00807	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP4A11—hypertension	9.51e-05	0.00797	CbGpPWpGaD
Temozolomide—CYP3A4—Estrogen metabolism—CYP1A1—hypertension	9.34e-05	0.00783	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2J2—hypertension	9.28e-05	0.00777	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A5—hypertension	9.27e-05	0.00777	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—PTGIS—hypertension	9.27e-05	0.00777	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP3A5—hypertension	9.15e-05	0.00767	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—CYP2C18—hypertension	9.03e-05	0.00757	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B2—hypertension	8.67e-05	0.00727	CbGpPWpGaD
Temozolomide—CYP3A4—Xenobiotics—CYP1A1—hypertension	8.59e-05	0.00719	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP11B2—hypertension	8.56e-05	0.00717	CbGpPWpGaD
Temozolomide—CYP3A4—Tamoxifen metabolism—CYP1A1—hypertension	8.26e-05	0.00692	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—hypertension	8.19e-05	0.00686	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP4A11—hypertension	7.81e-05	0.00654	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—ALDH2—hypertension	7.68e-05	0.00643	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—PTGIS—hypertension	7.52e-05	0.0063	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A5—hypertension	7.52e-05	0.0063	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—hypertension	7.3e-05	0.00612	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—hypertension	7.21e-05	0.00604	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—hypertension	7.03e-05	0.00589	CbGpPWpGaD
Temozolomide—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—hypertension	6.71e-05	0.00562	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—hypertension	6.64e-05	0.00556	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—GSTA5—hypertension	6.31e-05	0.00529	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—GSTA5—hypertension	6.23e-05	0.00522	CbGpPWpGaD
Temozolomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—hypertension	6.09e-05	0.0051	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—hypertension	6.01e-05	0.00504	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—GSTT2—hypertension	5.99e-05	0.00501	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—hypertension	5.93e-05	0.00497	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—hypertension	5.92e-05	0.00496	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—GSTT2—hypertension	5.9e-05	0.00495	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—CYP4F12—hypertension	5.71e-05	0.00478	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP4F12—hypertension	5.63e-05	0.00472	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—hypertension	5.59e-05	0.00468	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—hypertension	5.52e-05	0.00462	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—CYP19A1—hypertension	5.47e-05	0.00458	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—CYP11B1—hypertension	5.27e-05	0.00441	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—AHCY—hypertension	5.27e-05	0.00441	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP11B1—hypertension	5.2e-05	0.00435	CbGpPWpGaD
Temozolomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—hypertension	5.14e-05	0.0043	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—GSTM5—hypertension	5.09e-05	0.00426	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—hypertension	5.03e-05	0.00422	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—EPHX1—hypertension	5.02e-05	0.00421	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—EPHX2—hypertension	5.02e-05	0.00421	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—GSTM5—hypertension	5.02e-05	0.00421	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—CYP2J2—hypertension	4.93e-05	0.00413	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—CAT—hypertension	4.93e-05	0.00413	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—hypertension	4.87e-05	0.00408	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP2J2—hypertension	4.86e-05	0.00407	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—hypertension	4.53e-05	0.0038	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—hypertension	4.49e-05	0.00376	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—hypertension	4.42e-05	0.00371	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—CYP1A1—hypertension	4.41e-05	0.00369	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—hypertension	4.37e-05	0.00366	CbGpPWpGaD
Temozolomide—Diarrhoea—Olmesartan—hypertension	4.27e-05	0.000103	CcSEcCtD
Temozolomide—Headache—Eplerenone—hypertension	4.27e-05	0.000103	CcSEcCtD
Temozolomide—Rash—Nifedipine—hypertension	4.27e-05	0.000103	CcSEcCtD
Temozolomide—Nervous system disorder—Ramipril—hypertension	4.27e-05	0.000103	CcSEcCtD
Temozolomide—Dermatitis—Nifedipine—hypertension	4.26e-05	0.000103	CcSEcCtD
Temozolomide—Abdominal pain—Irbesartan—hypertension	4.26e-05	0.000103	CcSEcCtD
Temozolomide—Body temperature increased—Irbesartan—hypertension	4.26e-05	0.000103	CcSEcCtD
Temozolomide—Thrombocytopenia—Ramipril—hypertension	4.26e-05	0.000103	CcSEcCtD
Temozolomide—Oedema—Timolol—hypertension	4.25e-05	0.000103	CcSEcCtD
Temozolomide—Anaphylactic shock—Timolol—hypertension	4.25e-05	0.000103	CcSEcCtD
Temozolomide—Rash—Verapamil—hypertension	4.25e-05	0.000103	CcSEcCtD
Temozolomide—Urticaria—Hydrochlorothiazide—hypertension	4.25e-05	0.000103	CcSEcCtD
Temozolomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—hypertension	4.25e-05	0.00356	CbGpPWpGaD
Temozolomide—Dermatitis—Verapamil—hypertension	4.24e-05	0.000103	CcSEcCtD
Temozolomide—Headache—Nifedipine—hypertension	4.24e-05	0.000103	CcSEcCtD
Temozolomide—Pruritus—Clonidine—hypertension	4.23e-05	0.000102	CcSEcCtD
Temozolomide—Abdominal pain—Hydrochlorothiazide—hypertension	4.23e-05	0.000102	CcSEcCtD
Temozolomide—Body temperature increased—Hydrochlorothiazide—hypertension	4.23e-05	0.000102	CcSEcCtD
Temozolomide—Skin disorder—Ramipril—hypertension	4.22e-05	0.000102	CcSEcCtD
Temozolomide—Infection—Timolol—hypertension	4.22e-05	0.000102	CcSEcCtD
Temozolomide—Headache—Verapamil—hypertension	4.22e-05	0.000102	CcSEcCtD
Temozolomide—Hypersensitivity—Telmisartan—hypertension	4.22e-05	0.000102	CcSEcCtD
Temozolomide—Cough—Lisinopril—hypertension	4.22e-05	0.000102	CcSEcCtD
Temozolomide—Nausea—Diltiazem—hypertension	4.21e-05	0.000102	CcSEcCtD
Temozolomide—Nausea—Indapamide—hypertension	4.21e-05	0.000102	CcSEcCtD
Temozolomide—Hyperhidrosis—Ramipril—hypertension	4.2e-05	0.000102	CcSEcCtD
Temozolomide—Asthenia—Trandolapril—hypertension	4.18e-05	0.000101	CcSEcCtD
Temozolomide—Feeling abnormal—Losartan—hypertension	4.18e-05	0.000101	CcSEcCtD
Temozolomide—Urticaria—Furosemide—hypertension	4.18e-05	0.000101	CcSEcCtD
Temozolomide—Nervous system disorder—Timolol—hypertension	4.17e-05	0.000101	CcSEcCtD
Temozolomide—Nausea—Carvedilol—hypertension	4.17e-05	0.000101	CcSEcCtD
Temozolomide—Asthenia—Enalapril—hypertension	4.17e-05	0.000101	CcSEcCtD
Temozolomide—Body temperature increased—Furosemide—hypertension	4.16e-05	0.000101	CcSEcCtD
Temozolomide—Abdominal pain—Furosemide—hypertension	4.16e-05	0.000101	CcSEcCtD
Temozolomide—CYP3A4—Biological oxidations—CYP4A11—hypertension	4.15e-05	0.00348	CbGpPWpGaD
Temozolomide—Gastrointestinal pain—Losartan—hypertension	4.15e-05	0.0001	CcSEcCtD
Temozolomide—Dizziness—Valsartan—hypertension	4.15e-05	0.0001	CcSEcCtD
Temozolomide—Anorexia—Ramipril—hypertension	4.15e-05	0.0001	CcSEcCtD
Temozolomide—Urticaria—Betaxolol—hypertension	4.13e-05	0.0001	CcSEcCtD
Temozolomide—Skin disorder—Timolol—hypertension	4.13e-05	0.0001	CcSEcCtD
Temozolomide—Dizziness—Olmesartan—hypertension	4.13e-05	9.99e-05	CcSEcCtD
Temozolomide—Pruritus—Trandolapril—hypertension	4.13e-05	9.99e-05	CcSEcCtD
Temozolomide—Nausea—Doxazosin—hypertension	4.12e-05	9.98e-05	CcSEcCtD
Temozolomide—Arthralgia—Lisinopril—hypertension	4.11e-05	9.96e-05	CcSEcCtD
Temozolomide—Myalgia—Lisinopril—hypertension	4.11e-05	9.96e-05	CcSEcCtD
Temozolomide—Body temperature increased—Betaxolol—hypertension	4.11e-05	9.96e-05	CcSEcCtD
Temozolomide—Hyperhidrosis—Timolol—hypertension	4.11e-05	9.95e-05	CcSEcCtD
Temozolomide—Asthenia—Telmisartan—hypertension	4.11e-05	9.95e-05	CcSEcCtD
Temozolomide—Pruritus—Enalapril—hypertension	4.11e-05	9.95e-05	CcSEcCtD
Temozolomide—Anxiety—Lisinopril—hypertension	4.1e-05	9.93e-05	CcSEcCtD
Temozolomide—Diarrhoea—Clonidine—hypertension	4.09e-05	9.9e-05	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	4.09e-05	9.89e-05	CcSEcCtD
Temozolomide—Nausea—Fosinopril—hypertension	4.07e-05	9.86e-05	CcSEcCtD
Temozolomide—Discomfort—Lisinopril—hypertension	4.07e-05	9.84e-05	CcSEcCtD
Temozolomide—Anorexia—Timolol—hypertension	4.05e-05	9.81e-05	CcSEcCtD
Temozolomide—Pruritus—Telmisartan—hypertension	4.05e-05	9.81e-05	CcSEcCtD
Temozolomide—Nausea—Eplerenone—hypertension	4.05e-05	9.8e-05	CcSEcCtD
Temozolomide—Urticaria—Losartan—hypertension	4.03e-05	9.75e-05	CcSEcCtD
Temozolomide—Dry mouth—Lisinopril—hypertension	4.02e-05	9.74e-05	CcSEcCtD
Temozolomide—Nausea—Nifedipine—hypertension	4.02e-05	9.73e-05	CcSEcCtD
Temozolomide—Body temperature increased—Losartan—hypertension	4.01e-05	9.71e-05	CcSEcCtD
Temozolomide—Abdominal pain—Losartan—hypertension	4.01e-05	9.71e-05	CcSEcCtD
Temozolomide—Nausea—Verapamil—hypertension	4e-05	9.69e-05	CcSEcCtD
Temozolomide—Asthenia—Captopril—hypertension	4e-05	9.67e-05	CcSEcCtD
Temozolomide—CYP3A4—Biological oxidations—PTGIS—hypertension	3.99e-05	0.00335	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—CYP3A5—hypertension	3.99e-05	0.00335	CbGpPWpGaD
Temozolomide—Diarrhoea—Trandolapril—hypertension	3.99e-05	9.66e-05	CcSEcCtD
Temozolomide—Vomiting—Valsartan—hypertension	3.99e-05	9.65e-05	CcSEcCtD
Temozolomide—Confusional state—Lisinopril—hypertension	3.98e-05	9.63e-05	CcSEcCtD
Temozolomide—Diarrhoea—Enalapril—hypertension	3.97e-05	9.62e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Irbesartan—hypertension	3.97e-05	9.61e-05	CcSEcCtD
Temozolomide—Vomiting—Olmesartan—hypertension	3.97e-05	9.61e-05	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Ramipril—hypertension	3.96e-05	9.59e-05	CcSEcCtD
Temozolomide—Rash—Valsartan—hypertension	3.95e-05	9.57e-05	CcSEcCtD
Temozolomide—Dizziness—Clonidine—hypertension	3.95e-05	9.57e-05	CcSEcCtD
Temozolomide—Dermatitis—Valsartan—hypertension	3.95e-05	9.56e-05	CcSEcCtD
Temozolomide—Oedema—Lisinopril—hypertension	3.94e-05	9.55e-05	CcSEcCtD
Temozolomide—Anaphylactic shock—Lisinopril—hypertension	3.94e-05	9.55e-05	CcSEcCtD
Temozolomide—Pruritus—Captopril—hypertension	3.94e-05	9.54e-05	CcSEcCtD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP3A5—hypertension	3.94e-05	0.0033	CbGpPWpGaD
Temozolomide—Hypersensitivity—Hydrochlorothiazide—hypertension	3.94e-05	9.53e-05	CcSEcCtD
Temozolomide—Rash—Olmesartan—hypertension	3.94e-05	9.53e-05	CcSEcCtD
Temozolomide—Insomnia—Ramipril—hypertension	3.93e-05	9.52e-05	CcSEcCtD
Temozolomide—Dermatitis—Olmesartan—hypertension	3.93e-05	9.52e-05	CcSEcCtD
Temozolomide—Headache—Valsartan—hypertension	3.93e-05	9.51e-05	CcSEcCtD
Temozolomide—Diarrhoea—Telmisartan—hypertension	3.92e-05	9.49e-05	CcSEcCtD
Temozolomide—Infection—Lisinopril—hypertension	3.92e-05	9.49e-05	CcSEcCtD
Temozolomide—Headache—Olmesartan—hypertension	3.91e-05	9.46e-05	CcSEcCtD
Temozolomide—Paraesthesia—Ramipril—hypertension	3.91e-05	9.45e-05	CcSEcCtD
Temozolomide—Asthenia—Perindopril—hypertension	3.88e-05	9.39e-05	CcSEcCtD
Temozolomide—Dyspnoea—Ramipril—hypertension	3.88e-05	9.39e-05	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Timolol—hypertension	3.87e-05	9.38e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Furosemide—hypertension	3.87e-05	9.38e-05	CcSEcCtD
Temozolomide—Asthenia—Irbesartan—hypertension	3.87e-05	9.36e-05	CcSEcCtD
Temozolomide—Somnolence—Ramipril—hypertension	3.87e-05	9.36e-05	CcSEcCtD
Temozolomide—Thrombocytopenia—Lisinopril—hypertension	3.86e-05	9.35e-05	CcSEcCtD
Temozolomide—Dizziness—Trandolapril—hypertension	3.86e-05	9.33e-05	CcSEcCtD
Temozolomide—Insomnia—Timolol—hypertension	3.85e-05	9.31e-05	CcSEcCtD
Temozolomide—Dizziness—Enalapril—hypertension	3.84e-05	9.3e-05	CcSEcCtD
Temozolomide—Asthenia—Hydrochlorothiazide—hypertension	3.84e-05	9.28e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Betaxolol—hypertension	3.83e-05	9.28e-05	CcSEcCtD
Temozolomide—Skin disorder—Lisinopril—hypertension	3.83e-05	9.27e-05	CcSEcCtD
Temozolomide—Dyspepsia—Ramipril—hypertension	3.83e-05	9.27e-05	CcSEcCtD
Temozolomide—Pruritus—Perindopril—hypertension	3.83e-05	9.26e-05	CcSEcCtD
Temozolomide—Paraesthesia—Timolol—hypertension	3.82e-05	9.24e-05	CcSEcCtD
Temozolomide—Pruritus—Irbesartan—hypertension	3.81e-05	9.23e-05	CcSEcCtD
Temozolomide—Hyperhidrosis—Lisinopril—hypertension	3.81e-05	9.23e-05	CcSEcCtD
Temozolomide—Diarrhoea—Captopril—hypertension	3.81e-05	9.22e-05	CcSEcCtD
Temozolomide—Vomiting—Clonidine—hypertension	3.8e-05	9.2e-05	CcSEcCtD
Temozolomide—Dyspnoea—Timolol—hypertension	3.79e-05	9.18e-05	CcSEcCtD
Temozolomide—Dizziness—Telmisartan—hypertension	3.79e-05	9.17e-05	CcSEcCtD
Temozolomide—Pruritus—Hydrochlorothiazide—hypertension	3.78e-05	9.15e-05	CcSEcCtD
Temozolomide—Decreased appetite—Ramipril—hypertension	3.78e-05	9.15e-05	CcSEcCtD
Temozolomide—Somnolence—Timolol—hypertension	3.78e-05	9.15e-05	CcSEcCtD
Temozolomide—Asthenia—Furosemide—hypertension	3.77e-05	9.13e-05	CcSEcCtD
Temozolomide—Rash—Clonidine—hypertension	3.77e-05	9.12e-05	CcSEcCtD
Temozolomide—Dermatitis—Clonidine—hypertension	3.77e-05	9.12e-05	CcSEcCtD
Temozolomide—Anorexia—Lisinopril—hypertension	3.76e-05	9.1e-05	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Ramipril—hypertension	3.75e-05	9.09e-05	CcSEcCtD
Temozolomide—Fatigue—Ramipril—hypertension	3.75e-05	9.08e-05	CcSEcCtD
Temozolomide—Headache—Clonidine—hypertension	3.75e-05	9.07e-05	CcSEcCtD
Temozolomide—Dyspepsia—Timolol—hypertension	3.74e-05	9.06e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Losartan—hypertension	3.74e-05	9.05e-05	CcSEcCtD
Temozolomide—CYP3A4—Biological oxidations—CYP11B2—hypertension	3.74e-05	0.00313	CbGpPWpGaD
Temozolomide—Asthenia—Betaxolol—hypertension	3.73e-05	9.04e-05	CcSEcCtD
Temozolomide—Nausea—Valsartan—hypertension	3.73e-05	9.02e-05	CcSEcCtD
Temozolomide—Pruritus—Furosemide—hypertension	3.72e-05	9e-05	CcSEcCtD
Temozolomide—Constipation—Ramipril—hypertension	3.72e-05	9e-05	CcSEcCtD
Temozolomide—Nausea—Olmesartan—hypertension	3.71e-05	8.97e-05	CcSEcCtD
Temozolomide—Vomiting—Trandolapril—hypertension	3.71e-05	8.97e-05	CcSEcCtD
Temozolomide—Diarrhoea—Perindopril—hypertension	3.7e-05	8.96e-05	CcSEcCtD
Temozolomide—Decreased appetite—Timolol—hypertension	3.7e-05	8.95e-05	CcSEcCtD
Temozolomide—Vomiting—Enalapril—hypertension	3.69e-05	8.94e-05	CcSEcCtD
Temozolomide—Diarrhoea—Irbesartan—hypertension	3.69e-05	8.93e-05	CcSEcCtD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP11B2—hypertension	3.68e-05	0.00309	CbGpPWpGaD
Temozolomide—Dizziness—Captopril—hypertension	3.68e-05	8.92e-05	CcSEcCtD
Temozolomide—Pruritus—Betaxolol—hypertension	3.68e-05	8.91e-05	CcSEcCtD
Temozolomide—Rash—Trandolapril—hypertension	3.68e-05	8.9e-05	CcSEcCtD
Temozolomide—Dermatitis—Trandolapril—hypertension	3.67e-05	8.89e-05	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Timolol—hypertension	3.67e-05	8.89e-05	CcSEcCtD
Temozolomide—Fatigue—Timolol—hypertension	3.67e-05	8.87e-05	CcSEcCtD
Temozolomide—Rash—Enalapril—hypertension	3.66e-05	8.86e-05	CcSEcCtD
Temozolomide—Dermatitis—Enalapril—hypertension	3.66e-05	8.85e-05	CcSEcCtD
Temozolomide—Diarrhoea—Hydrochlorothiazide—hypertension	3.66e-05	8.85e-05	CcSEcCtD
Temozolomide—Headache—Trandolapril—hypertension	3.65e-05	8.84e-05	CcSEcCtD
Temozolomide—Vomiting—Telmisartan—hypertension	3.64e-05	8.82e-05	CcSEcCtD
Temozolomide—Asthenia—Losartan—hypertension	3.64e-05	8.81e-05	CcSEcCtD
Temozolomide—Headache—Enalapril—hypertension	3.64e-05	8.81e-05	CcSEcCtD
Temozolomide—Pain—Timolol—hypertension	3.64e-05	8.8e-05	CcSEcCtD
Temozolomide—Rash—Telmisartan—hypertension	3.61e-05	8.74e-05	CcSEcCtD
Temozolomide—Dermatitis—Telmisartan—hypertension	3.61e-05	8.73e-05	CcSEcCtD
Temozolomide—Diarrhoea—Furosemide—hypertension	3.6e-05	8.71e-05	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Lisinopril—hypertension	3.59e-05	8.7e-05	CcSEcCtD
Temozolomide—Pruritus—Losartan—hypertension	3.59e-05	8.69e-05	CcSEcCtD
Temozolomide—Headache—Telmisartan—hypertension	3.59e-05	8.69e-05	CcSEcCtD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—hypertension	3.59e-05	0.003	CbGpPWpGaD
Temozolomide—Feeling abnormal—Ramipril—hypertension	3.58e-05	8.68e-05	CcSEcCtD
Temozolomide—Dizziness—Perindopril—hypertension	3.58e-05	8.66e-05	CcSEcCtD
Temozolomide—Insomnia—Lisinopril—hypertension	3.57e-05	8.64e-05	CcSEcCtD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—hypertension	3.57e-05	0.00299	CbGpPWpGaD
Temozolomide—Dizziness—Irbesartan—hypertension	3.56e-05	8.63e-05	CcSEcCtD
Temozolomide—Diarrhoea—Betaxolol—hypertension	3.56e-05	8.62e-05	CcSEcCtD
Temozolomide—Gastrointestinal pain—Ramipril—hypertension	3.56e-05	8.61e-05	CcSEcCtD
Temozolomide—Nausea—Clonidine—hypertension	3.55e-05	8.6e-05	CcSEcCtD
Temozolomide—Paraesthesia—Lisinopril—hypertension	3.54e-05	8.57e-05	CcSEcCtD
Temozolomide—Vomiting—Captopril—hypertension	3.54e-05	8.57e-05	CcSEcCtD
Temozolomide—Dizziness—Hydrochlorothiazide—hypertension	3.53e-05	8.56e-05	CcSEcCtD
Temozolomide—CYP3A4—Biological oxidations—TBXAS1—hypertension	3.53e-05	0.00296	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—hypertension	3.52e-05	0.00295	CbGpPWpGaD
Temozolomide—Dyspnoea—Lisinopril—hypertension	3.52e-05	8.51e-05	CcSEcCtD
Temozolomide—Rash—Captopril—hypertension	3.51e-05	8.5e-05	CcSEcCtD
Temozolomide—Dermatitis—Captopril—hypertension	3.51e-05	8.49e-05	CcSEcCtD
Temozolomide—Somnolence—Lisinopril—hypertension	3.51e-05	8.49e-05	CcSEcCtD
Temozolomide—Feeling abnormal—Timolol—hypertension	3.5e-05	8.48e-05	CcSEcCtD
Temozolomide—Headache—Captopril—hypertension	3.49e-05	8.45e-05	CcSEcCtD
Temozolomide—Gastrointestinal pain—Timolol—hypertension	3.48e-05	8.42e-05	CcSEcCtD
Temozolomide—Dizziness—Furosemide—hypertension	3.48e-05	8.41e-05	CcSEcCtD
Temozolomide—Dyspepsia—Lisinopril—hypertension	3.47e-05	8.4e-05	CcSEcCtD
Temozolomide—Diarrhoea—Losartan—hypertension	3.47e-05	8.4e-05	CcSEcCtD
Temozolomide—Nausea—Trandolapril—hypertension	3.46e-05	8.38e-05	CcSEcCtD
Temozolomide—Urticaria—Ramipril—hypertension	3.46e-05	8.36e-05	CcSEcCtD
Temozolomide—Nausea—Enalapril—hypertension	3.45e-05	8.35e-05	CcSEcCtD
Temozolomide—Dizziness—Betaxolol—hypertension	3.44e-05	8.33e-05	CcSEcCtD
Temozolomide—Vomiting—Perindopril—hypertension	3.44e-05	8.32e-05	CcSEcCtD
Temozolomide—Abdominal pain—Ramipril—hypertension	3.44e-05	8.32e-05	CcSEcCtD
Temozolomide—Body temperature increased—Ramipril—hypertension	3.44e-05	8.32e-05	CcSEcCtD
Temozolomide—Decreased appetite—Lisinopril—hypertension	3.43e-05	8.3e-05	CcSEcCtD
Temozolomide—Vomiting—Irbesartan—hypertension	3.43e-05	8.3e-05	CcSEcCtD
Temozolomide—Rash—Perindopril—hypertension	3.41e-05	8.25e-05	CcSEcCtD
Temozolomide—Dermatitis—Perindopril—hypertension	3.41e-05	8.25e-05	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Lisinopril—hypertension	3.41e-05	8.24e-05	CcSEcCtD
Temozolomide—Nausea—Telmisartan—hypertension	3.4e-05	8.24e-05	CcSEcCtD
Temozolomide—Fatigue—Lisinopril—hypertension	3.4e-05	8.23e-05	CcSEcCtD
Temozolomide—Vomiting—Hydrochlorothiazide—hypertension	3.4e-05	8.23e-05	CcSEcCtD
Temozolomide—Rash—Irbesartan—hypertension	3.4e-05	8.23e-05	CcSEcCtD
Temozolomide—Dermatitis—Irbesartan—hypertension	3.4e-05	8.22e-05	CcSEcCtD
Temozolomide—Headache—Perindopril—hypertension	3.39e-05	8.2e-05	CcSEcCtD
Temozolomide—Urticaria—Timolol—hypertension	3.38e-05	8.18e-05	CcSEcCtD
Temozolomide—Headache—Irbesartan—hypertension	3.38e-05	8.17e-05	CcSEcCtD
Temozolomide—Pain—Lisinopril—hypertension	3.37e-05	8.16e-05	CcSEcCtD
Temozolomide—Constipation—Lisinopril—hypertension	3.37e-05	8.16e-05	CcSEcCtD
Temozolomide—Rash—Hydrochlorothiazide—hypertension	3.37e-05	8.16e-05	CcSEcCtD
Temozolomide—Dermatitis—Hydrochlorothiazide—hypertension	3.37e-05	8.15e-05	CcSEcCtD
Temozolomide—Abdominal pain—Timolol—hypertension	3.36e-05	8.14e-05	CcSEcCtD
Temozolomide—Body temperature increased—Timolol—hypertension	3.36e-05	8.14e-05	CcSEcCtD
Temozolomide—Dizziness—Losartan—hypertension	3.35e-05	8.12e-05	CcSEcCtD
Temozolomide—Headache—Hydrochlorothiazide—hypertension	3.35e-05	8.11e-05	CcSEcCtD
Temozolomide—Vomiting—Furosemide—hypertension	3.34e-05	8.09e-05	CcSEcCtD
Temozolomide—Rash—Furosemide—hypertension	3.31e-05	8.02e-05	CcSEcCtD
Temozolomide—Dermatitis—Furosemide—hypertension	3.31e-05	8.02e-05	CcSEcCtD
Temozolomide—Vomiting—Betaxolol—hypertension	3.31e-05	8.01e-05	CcSEcCtD
Temozolomide—Nausea—Captopril—hypertension	3.31e-05	8.01e-05	CcSEcCtD
Temozolomide—Headache—Furosemide—hypertension	3.29e-05	7.97e-05	CcSEcCtD
Temozolomide—Rash—Betaxolol—hypertension	3.28e-05	7.94e-05	CcSEcCtD
Temozolomide—Dermatitis—Betaxolol—hypertension	3.28e-05	7.94e-05	CcSEcCtD
Temozolomide—Headache—Betaxolol—hypertension	3.26e-05	7.89e-05	CcSEcCtD
Temozolomide—Feeling abnormal—Lisinopril—hypertension	3.25e-05	7.87e-05	CcSEcCtD
Temozolomide—Gastrointestinal pain—Lisinopril—hypertension	3.23e-05	7.81e-05	CcSEcCtD
Temozolomide—Vomiting—Losartan—hypertension	3.23e-05	7.81e-05	CcSEcCtD
Temozolomide—Nausea—Perindopril—hypertension	3.21e-05	7.78e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Ramipril—hypertension	3.2e-05	7.76e-05	CcSEcCtD
Temozolomide—Nausea—Irbesartan—hypertension	3.2e-05	7.75e-05	CcSEcCtD
Temozolomide—Rash—Losartan—hypertension	3.2e-05	7.74e-05	CcSEcCtD
Temozolomide—Dermatitis—Losartan—hypertension	3.2e-05	7.73e-05	CcSEcCtD
Temozolomide—Headache—Losartan—hypertension	3.18e-05	7.69e-05	CcSEcCtD
Temozolomide—Nausea—Hydrochlorothiazide—hypertension	3.18e-05	7.69e-05	CcSEcCtD
Temozolomide—CYP3A4—Biological oxidations—CYP2C18—hypertension	3.14e-05	0.00263	CbGpPWpGaD
Temozolomide—Urticaria—Lisinopril—hypertension	3.13e-05	7.59e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Timolol—hypertension	3.13e-05	7.58e-05	CcSEcCtD
Temozolomide—Nausea—Furosemide—hypertension	3.12e-05	7.56e-05	CcSEcCtD
Temozolomide—Asthenia—Ramipril—hypertension	3.12e-05	7.55e-05	CcSEcCtD
Temozolomide—Abdominal pain—Lisinopril—hypertension	3.12e-05	7.55e-05	CcSEcCtD
Temozolomide—Body temperature increased—Lisinopril—hypertension	3.12e-05	7.55e-05	CcSEcCtD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP2C18—hypertension	3.1e-05	0.0026	CbGpPWpGaD
Temozolomide—Nausea—Betaxolol—hypertension	3.09e-05	7.48e-05	CcSEcCtD
Temozolomide—Pruritus—Ramipril—hypertension	3.08e-05	7.45e-05	CcSEcCtD
Temozolomide—Asthenia—Timolol—hypertension	3.05e-05	7.38e-05	CcSEcCtD
Temozolomide—Nausea—Losartan—hypertension	3.01e-05	7.29e-05	CcSEcCtD
Temozolomide—Pruritus—Timolol—hypertension	3.01e-05	7.28e-05	CcSEcCtD
Temozolomide—Diarrhoea—Ramipril—hypertension	2.98e-05	7.2e-05	CcSEcCtD
Temozolomide—Diarrhoea—Timolol—hypertension	2.91e-05	7.04e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Lisinopril—hypertension	2.91e-05	7.03e-05	CcSEcCtD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—hypertension	2.89e-05	0.00242	CbGpPWpGaD
Temozolomide—Dizziness—Ramipril—hypertension	2.88e-05	6.96e-05	CcSEcCtD
Temozolomide—Asthenia—Lisinopril—hypertension	2.83e-05	6.85e-05	CcSEcCtD
Temozolomide—Dizziness—Timolol—hypertension	2.81e-05	6.81e-05	CcSEcCtD
Temozolomide—Pruritus—Lisinopril—hypertension	2.79e-05	6.76e-05	CcSEcCtD
Temozolomide—Vomiting—Ramipril—hypertension	2.77e-05	6.69e-05	CcSEcCtD
Temozolomide—CYP3A4—Metapathway biotransformation—GPX3—hypertension	2.75e-05	0.0023	CbGpPWpGaD
Temozolomide—Rash—Ramipril—hypertension	2.74e-05	6.64e-05	CcSEcCtD
Temozolomide—Dermatitis—Ramipril—hypertension	2.74e-05	6.63e-05	CcSEcCtD
Temozolomide—Headache—Ramipril—hypertension	2.72e-05	6.6e-05	CcSEcCtD
Temozolomide—Vomiting—Timolol—hypertension	2.7e-05	6.54e-05	CcSEcCtD
Temozolomide—Diarrhoea—Lisinopril—hypertension	2.7e-05	6.53e-05	CcSEcCtD
Temozolomide—Rash—Timolol—hypertension	2.68e-05	6.49e-05	CcSEcCtD
Temozolomide—Dermatitis—Timolol—hypertension	2.68e-05	6.48e-05	CcSEcCtD
Temozolomide—CYP3A4—Biological oxidations—ALDH2—hypertension	2.67e-05	0.00224	CbGpPWpGaD
Temozolomide—Headache—Timolol—hypertension	2.66e-05	6.45e-05	CcSEcCtD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypertension	2.66e-05	0.00223	CbGpPWpGaD
Temozolomide—Dizziness—Lisinopril—hypertension	2.61e-05	6.31e-05	CcSEcCtD
Temozolomide—CYP3A4—Biological oxidations—CYP11A1—hypertension	2.59e-05	0.00217	CbGpPWpGaD
Temozolomide—Nausea—Ramipril—hypertension	2.58e-05	6.25e-05	CcSEcCtD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP11A1—hypertension	2.55e-05	0.00214	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—GSTT1—hypertension	2.54e-05	0.00213	CbGpPWpGaD
Temozolomide—Nausea—Timolol—hypertension	2.53e-05	6.11e-05	CcSEcCtD
Temozolomide—CYP3A4—Biological oxidations—GCLC—hypertension	2.51e-05	0.00211	CbGpPWpGaD
Temozolomide—Vomiting—Lisinopril—hypertension	2.51e-05	6.07e-05	CcSEcCtD
Temozolomide—Rash—Lisinopril—hypertension	2.49e-05	6.02e-05	CcSEcCtD
Temozolomide—Dermatitis—Lisinopril—hypertension	2.48e-05	6.01e-05	CcSEcCtD
Temozolomide—Headache—Lisinopril—hypertension	2.47e-05	5.98e-05	CcSEcCtD
Temozolomide—CYP3A4—Biological oxidations—CYP17A1—hypertension	2.41e-05	0.00202	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—PTGS1—hypertension	2.38e-05	0.002	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP17A1—hypertension	2.37e-05	0.00199	CbGpPWpGaD
Temozolomide—Nausea—Lisinopril—hypertension	2.34e-05	5.67e-05	CcSEcCtD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypertension	2.16e-05	0.00181	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—CYP19A1—hypertension	1.91e-05	0.0016	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP19A1—hypertension	1.88e-05	0.00157	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—COMT—hypertension	1.77e-05	0.00148	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—COMT—hypertension	1.75e-05	0.00146	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—GSTM1—hypertension	1.62e-05	0.00136	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—GSTM1—hypertension	1.6e-05	0.00134	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—CYP1A1—hypertension	1.54e-05	0.00129	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—FAH—hypertension	1.52e-05	0.00127	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP1A1—hypertension	1.51e-05	0.00127	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HYAL2—hypertension	1.15e-05	0.000962	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HAS2—hypertension	1.15e-05	0.000962	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HAS3—hypertension	1.15e-05	0.000962	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—QDPR—hypertension	1.15e-05	0.000962	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PNMT—hypertension	1.15e-05	0.000962	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HAS1—hypertension	1.15e-05	0.000962	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—POMC—hypertension	1.14e-05	0.000959	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GSTA5—hypertension	1.08e-05	0.000905	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—MDH1—hypertension	1.02e-05	0.000858	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HYAL1—hypertension	1.02e-05	0.000858	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GSTT2—hypertension	1.02e-05	0.000858	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CDO1—hypertension	1.02e-05	0.000858	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CPS1—hypertension	1.02e-05	0.000858	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GCH1—hypertension	9.77e-06	0.000818	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP4F12—hypertension	9.77e-06	0.000818	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PLCD1—hypertension	9.36e-06	0.000784	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—AHCY—hypertension	9.01e-06	0.000755	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP11B1—hypertension	9.01e-06	0.000755	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ALOX12—hypertension	8.7e-06	0.000729	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—EPHX2—hypertension	8.7e-06	0.000729	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GSTM5—hypertension	8.7e-06	0.000729	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GBA—hypertension	8.7e-06	0.000729	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—DBH—hypertension	8.7e-06	0.000729	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP2J2—hypertension	8.43e-06	0.000706	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ARG1—hypertension	8.18e-06	0.000686	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GLS2—hypertension	8.18e-06	0.000686	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—COX5B—hypertension	8.18e-06	0.000686	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—DECR1—hypertension	8.18e-06	0.000686	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ALAD—hypertension	7.76e-06	0.00065	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PLCE1—hypertension	7.4e-06	0.00062	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—STS—hypertension	7.4e-06	0.00062	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ALDH7A1—hypertension	7.4e-06	0.00062	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CBS—hypertension	7.1e-06	0.000594	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP4A11—hypertension	7.1e-06	0.000594	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ARG2—hypertension	7.1e-06	0.000594	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—XDH—hypertension	6.96e-06	0.000583	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP3A5—hypertension	6.83e-06	0.000572	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SLC5A2—hypertension	6.83e-06	0.000572	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PTGIS—hypertension	6.83e-06	0.000572	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—TPH1—hypertension	6.6e-06	0.000553	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HSD11B1—hypertension	6.6e-06	0.000553	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ABCC1—hypertension	6.6e-06	0.000553	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—UCP3—hypertension	6.6e-06	0.000553	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—UCP2—hypertension	6.6e-06	0.000553	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ALAS1—hypertension	6.39e-06	0.000535	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SLC2A3—hypertension	6.39e-06	0.000535	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP11B2—hypertension	6.39e-06	0.000535	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HSD3B1—hypertension	6.29e-06	0.000527	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ADA—hypertension	6.29e-06	0.000527	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—AQP1—hypertension	6.2e-06	0.00052	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—FADS1—hypertension	6.2e-06	0.00052	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CA9—hypertension	6.03e-06	0.000505	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—TBXAS1—hypertension	6.03e-06	0.000505	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ALOX5AP—hypertension	5.88e-06	0.000493	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ALOX15—hypertension	5.88e-06	0.000493	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—LHB—hypertension	5.74e-06	0.000481	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HADHA—hypertension	5.74e-06	0.000481	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—LPA—hypertension	5.61e-06	0.00047	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HSD3B2—hypertension	5.61e-06	0.00047	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—KCNJ11—hypertension	5.61e-06	0.00047	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—LRP2—hypertension	5.38e-06	0.00045	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP2C18—hypertension	5.38e-06	0.00045	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HSPG2—hypertension	5.18e-06	0.000434	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ALOX5—hypertension	5e-06	0.000419	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GLP1R—hypertension	5e-06	0.000419	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ALDH2—hypertension	4.57e-06	0.000383	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HBA1—hypertension	4.46e-06	0.000373	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP11A1—hypertension	4.43e-06	0.000371	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GSTT1—hypertension	4.35e-06	0.000364	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SLC9A1—hypertension	4.35e-06	0.000364	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GCLC—hypertension	4.3e-06	0.00036	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CETP—hypertension	4.3e-06	0.00036	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP17A1—hypertension	4.12e-06	0.000345	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ENO1—hypertension	4.08e-06	0.000341	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PTGS1—hypertension	4.08e-06	0.000341	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CTGF—hypertension	3.92e-06	0.000329	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HMGCR—hypertension	3.89e-06	0.000326	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GOT2—hypertension	3.89e-06	0.000326	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ADRA2A—hypertension	3.8e-06	0.000319	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—TH—hypertension	3.56e-06	0.000298	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CALM2—hypertension	3.55e-06	0.000297	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SLC2A4—hypertension	3.47e-06	0.00029	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GCG—hypertension	3.47e-06	0.00029	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GOT1—hypertension	3.36e-06	0.000281	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—STK11—hypertension	3.26e-06	0.000273	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP19A1—hypertension	3.26e-06	0.000273	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—COMT—hypertension	3.03e-06	0.000254	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PPARGC1A—hypertension	2.99e-06	0.00025	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GNB3—hypertension	2.99e-06	0.00025	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HMOX1—hypertension	2.97e-06	0.000249	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CAT—hypertension	2.93e-06	0.000246	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GNAS—hypertension	2.91e-06	0.000244	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—APOB—hypertension	2.85e-06	0.000239	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GSTM1—hypertension	2.77e-06	0.000232	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—LPL—hypertension	2.72e-06	0.000228	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ADCY5—hypertension	2.66e-06	0.000223	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GPX1—hypertension	2.65e-06	0.000222	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP1A1—hypertension	2.63e-06	0.00022	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PRKCA—hypertension	2.63e-06	0.00022	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CD36—hypertension	2.58e-06	0.000216	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—MTHFR—hypertension	2.45e-06	0.000205	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PPARA—hypertension	2.4e-06	0.000201	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—AGT—hypertension	2.33e-06	0.000195	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CALM1—hypertension	2.29e-06	0.000192	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—APOE—hypertension	2.28e-06	0.000191	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CAV1—hypertension	2.26e-06	0.000189	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—APOA1—hypertension	2.25e-06	0.000189	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PPARG—hypertension	1.99e-06	0.000166	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—POMC—hypertension	1.96e-06	0.000164	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—INS—hypertension	1.95e-06	0.000163	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ALB—hypertension	1.79e-06	0.00015	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PIK3R1—hypertension	1.71e-06	0.000143	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—NOS3—hypertension	1.71e-06	0.000143	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PTGS2—hypertension	1.56e-06	0.000131	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PTEN—hypertension	1.36e-06	0.000114	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—EP300—hypertension	1.3e-06	0.000109	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—AKT1—hypertension	7.85e-07	6.58e-05	CbGpPWpGaD
